Cargando…
Genetic and proteomic approaches to identify cancer drug targets
While target-based small-molecule discovery has taken centre-stage in the pharmaceutical industry, there are many cancer-promoting proteins not easily addressed with a traditional target-based screening approach. In order to address this problem, as well as to identify modulators of biological state...
Autores principales: | Roti, G, Stegmaier, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262130/ https://www.ncbi.nlm.nih.gov/pubmed/22166799 http://dx.doi.org/10.1038/bjc.2011.543 |
Ejemplares similares
-
New Approaches to Target T-ALL
por: Roti, Giovanni, et al.
Publicado: (2014) -
Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
por: Cakir, Merve, et al.
Publicado: (2021) -
Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach
por: Rajesh, Srujan, et al.
Publicado: (2021) -
Effective combinations of anti-cancer and targeted drugs for pancreatic cancer treatment
por: Nishimoto, Arata
Publicado: (2022) -
Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer
por: Chan, S
Publicado: (2004)